Strategic guidance from
proven professionals

Lori Mixson, Ph.D.

Senior Director, Biostatistics

Dr. Mixson has 20+ years of experience in planning, executing, and analyzing preclinical and clinical pharmacology studies as well as experience in strategic planning and execution of entire drug development programs (from preclinical IND enabling studies through Phase 1 POC to late stage studies leading to marketing registration).  She has a special interest in early clinical development including clinical / translational pharmacology, PK/PD modeling, adaptive designs and personalized medicine. Dr. Mixson has therapeutic area experience in cardio-metabolic disorders, neuroscience (including analgesia, anesthesia, depression and Alzheimer’s Disease), oncology, dermatology, infectious diseases and vaccines.

Education

  • Doctorate of Philosophy, Biomathematics / Statistics
    • North Carolina State University, Raleigh, NC
  • Bachelor of Science, Chemistry
    • Duke University, Durham, NC